MENU
TAK
Stock ticker: NYSE
PRICE
CHANGE
CAPITALIZATION

TAK Price Prediction, Takeda Pharmaceutical Company Limited AI Recommendations

TAK
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
A.I.Advisor
published Dividends

TAK paid dividends on July 08, 2024

Takeda Pharmaceutical Company Limited TAK Stock Dividends
А dividend of $0.29 per share was paid with a record date of July 08, 2024, and an ex-dividend date of March 27, 2024. Read more...
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are ZOETIS (NYSE:ZTS), Teva Pharmaceutical Industries Limited (NYSE:TEVA), Elanco Animal Health (NYSE:ELAN), Intra-Cellular Therapies (NASDAQ:ITCI), Bausch Health Companies (NYSE:BHC), Tilray Brands (NASDAQ:TLRY), Avadel Pharmaceuticals plc (NASDAQ:AVDL), Canopy Growth Corp (NASDAQ:CGC), Aurora Cannabis (NASDAQ:ACB), Journey Medical Corp (NASDAQ:DERM).

Industry description

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

Market Cap

The average market capitalization across the Pharmaceuticals: Other Industry is 3.23B. The market cap for tickers in the group ranges from 246 to 77.48B. ZTS holds the highest valuation in this group at 77.48B. The lowest valued company is PEMTF at 246.

High and low price notable news

The average weekly price growth across all stocks in the Pharmaceuticals: Other Industry was 1%. For the same Industry, the average monthly price growth was 2%, and the average quarterly price growth was 41%. MGWFF experienced the highest price growth at 122%, while VPHIF experienced the biggest fall at -50%.

Volume

The average weekly volume growth across all stocks in the Pharmaceuticals: Other Industry was -45%. For the same stocks of the Industry, the average monthly volume growth was 58% and the average quarterly volume growth was -27%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 53
P/E Growth Rating: 72
Price Growth Rating: 59
SMR Rating: 86
Profit Risk Rating: 90
Seasonality Score: -7 (-100 ... +100)
View a ticker or compare two or three
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a pharmaceutical products manufacturer

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
1-1, Nihonbashi-Honcho 2-Chome
Phone
+81 332782306
Employees
49095
Web
https://www.takeda.com